2397 — DNA Chip Research Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapHigh Flyer

Annual balance sheet for DNA Chip Research, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	621	489	275	388	411
Net Total Accounts Receivable
Net Total Receivables	150	173	206	190	201
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	825	710	525	677	678
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	17.4	2.44	114	108	133
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,021	890	871	982	991
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	81.7	99.3	121	209	269
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	90.4	110	160	250	317
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	931	781	711	732	674
Total Liabilities & Shareholders' Equity	1,021	890	871	982	991
Total Common Shares Outstanding